The investigational HIV integrase inhibitor GSK1265744 was well tolerated with no notable safety concerns in a meta-analysis of 8 studies testing the drug as either a pill or a long-acting injection, researchers reported at the recent 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver.
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/4320-icaac-2013-new-integrase-inhibitor-gsk1265744-safe-and-well-tolerated-in-8-studies
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/4320-icaac-2013-new-integrase-inhibitor-gsk1265744-safe-and-well-tolerated-in-8-studies
No comments:
Post a Comment